Immunovant, Inc. (IMVT) SEC Filings https://www.immunovant.com/investors/sec-filings/all-sec-filings/rss Immunovant, Inc. (IMVT) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_d6ae8ad1fc90c30ceeec0c8ff3e3b1be/immunovant/files/theme/images/logo-sm.jpg Immunovant, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001172661-26-003481/0001172661-26-003481.pdf Fri, 14 Aug 26 08:27:28 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001172661-26-003481/0001172661-26-003481.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000101/0001764013-26-000101.pdf Thu, 06 Aug 26 07:29:49 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000101/0001764013-26-000101.pdf <![CDATA[8-K - Current report]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000100/0001764013-26-000100.pdf Thu, 06 Aug 26 07:16:04 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000100/0001764013-26-000100.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001643071-26-000007/0001643071-26-000007.pdf Fri, 24 Jul 26 17:59:30 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001643071-26-000007/0001643071-26-000007.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001618670-26-000004/0001618670-26-000004.pdf Fri, 24 Jul 26 17:58:24 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001618670-26-000004/0001618670-26-000004.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001702969-26-000010/0001702969-26-000010.pdf Fri, 24 Jul 26 17:57:48 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001702969-26-000010/0001702969-26-000010.pdf <![CDATA[ARS - Annual Report to Security Holders]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000094/0001764013-26-000094.pdf Wed, 22 Jul 26 16:20:39 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000094/0001764013-26-000094.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000093/0001764013-26-000093.pdf Wed, 22 Jul 26 16:13:53 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000093/0001764013-26-000093.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000092/0001764013-26-000092.pdf Wed, 22 Jul 26 16:11:06 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000092/0001764013-26-000092.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000083/0001764013-26-000083.pdf Fri, 10 Jul 26 16:15:51 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000083/0001764013-26-000083.pdf